Holen Sie sich die Stockscreener-App
21.48
2.29%
0.48
Vorhandelsmarkt:
21.55
0.07
+0.33%
Schlusskurs vom Vortag:
$21.00
Offen:
$21.17
24-Stunden-Volumen:
2.17M
Relative Volume:
1.28
Marktkapitalisierung:
$1.83B
Einnahmen:
$1.13B
Nettoeinkommen (Verlust:
$62.75M
KGV:
34.10
EPS:
0.63
Netto-Cashflow:
$170.92M
1W Leistung:
+7.19%
1M Leistung:
+49.79%
6M Leistung:
-22.71%
1J Leistung:
-42.58%
1-Tages-Spanne:
$21.09
$21.66
1-Wochen-Bereich:
$19.94
$21.66
52-Wochen-Spanne:
$13.39
$42.08
Progyny Inc Stock (PGNY) Company Profile
Firmenname
Progyny Inc
Sektor
Branche
Telefon
212-888-3124
Adresse
1359 BROADWAY, NEW YORK, NY
Vergleichen Sie PGNY mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PGNY
Progyny Inc
|
21.48 | 1.83B | 1.13B | 62.75M | 170.92M | 0.63 |
|
VEEV
Veeva Systems Inc
|
223.04 | 36.21B | 2.66B | 665.91M | 1.08B | 4.05 |
|
SOLV
Solventum Corp
|
74.02 | 12.79B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
DOCS
Doximity Inc
|
55.52 | 10.37B | 516.85M | 174.11M | 217.38M | 0.87 |
|
HQY
Healthequity Inc
|
104.74 | 9.08B | 1.15B | 96.70M | -161.99M | 1.09 |
|
TEM
Tempus Ai Inc
|
47.64 | 7.50B | 640.44M | -743.28M | -206.93M | -11.29 |
Progyny Inc Stock (PGNY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-02 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-11-13 | Herabstufung | Truist | Buy → Hold |
| 2024-09-19 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-08-07 | Herabstufung | BTIG Research | Buy → Neutral |
| 2024-08-07 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2024-08-07 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-07-16 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-05-10 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-09-27 | Eingeleitet | Canaccord Genuity | Buy |
| 2023-05-22 | Eingeleitet | BTIG Research | Buy |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-01-05 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-09-07 | Eingeleitet | Truist | Buy |
| 2021-12-02 | Eingeleitet | Jefferies | Buy |
| 2021-11-22 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-09-30 | Eingeleitet | Berenberg | Buy |
| 2021-08-12 | Eingeleitet | Barclays | Overweight |
| 2021-06-02 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-04-29 | Fortgesetzt | JP Morgan | Overweight |
| 2021-03-10 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-07-01 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-02 | Eingeleitet | Guggenheim | Buy |
| 2019-11-19 | Eingeleitet | Citigroup | Buy |
| 2019-11-19 | Eingeleitet | Goldman | Buy |
| 2019-11-19 | Eingeleitet | JP Morgan | Overweight |
| 2019-11-19 | Eingeleitet | Piper Jaffray | Overweight |
| 2019-11-19 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Progyny Inc Aktie (PGNY) Neueste Nachrichten
(PGNY) On The My Stocks Page - Stock Traders Daily
Progyny shares surge 54% after November Fair Value signal flagged undervaluation - MSN
PGNY Stockholders: Robbins LLP is Investigating the Officers and Directors of Progyny, Inc. to Determine if They Breached Fiduciary Duties Owed to Shareholders - Kilgore News Herald
Progyny adds healthcare veteran Debra Morris to board By Investing.com - Investing.com Australia
Progyny appoints Debra Morris as new board member By Investing.com - Investing.com Australia
IVF treatment demand drops after Alabama ruling, and Progyny’s stock tumbles - MSN
Progyny appoints Debra Morris as new board member - MSN
Progyny, Inc Appoints Debra Morris to Its Board of Directors and Compensation Committee - Marketscreener.com
Progyny adds healthcare veteran Debra Morris to board - MSN
Progyny Strengthens Leadership with New Director Appointment - TipRanks
Progyny Appoints Healthcare Veteran Debra Morris to Board of Directors - GlobeNewswire
Progyny Strengthens Board with Healthcare Veteran Debra Morris, AccessHope President Joins - StockTitan
Rep. Josh Gottheimer Sells Progyny, Inc. (NASDAQ:PGNY) Shares - MarketBeat
Progyny: The Growth Story Remains Intact (NASDAQ:PGNY) - Seeking Alpha
Progyny FY2024 EPS Estimate Increased by Leerink Partnrs - MarketBeat
Progyny sees Q4 results slightly above guidance ranges provided in November - MSN
Leibman Financial Services Inc. Grows Stock Position in Progyny, Inc. (NASDAQ:PGNY) - MarketBeat
Progyny Stock Rises 7% on Improved 4Q Outlook - MarketWatch
Progyny (NASDAQ:PGNY) Shares Gap UpShould You Buy? - MarketBeat
Progyny's premarket value rises 5.8% on improved 4Q forecast By Investing.com - Investing.com Canada
Progyny to Discuss Updated Financial Expectations at Upcoming JP Morgan Healthcare Conference - The Manila Times
Cigna Healthcare Expands Access to Fertility and Family-Building Benefits and Services - Cigna Newsroom
Cigna Healthcare Expands Access to Fertility and Family-Building Benefits and Services – Company Announcement - Financial Times
Progyny Raises Q4 Guidance as Member Activity Strengthens, CEO to Present at JPM Conference - StockTitan
Progyny, Inc.'s (NASDAQ:PGNY) P/E Is Still On The Mark Following 28% Share Price Bounce - Simply Wall St
(PGNY) Investment Report - Stock Traders Daily
Progyny (NASDAQ:PGNY) Trading Up 3.1%Time to Buy? - MarketBeat
Progyny, Inc. (NASDAQ:PGNY) Shares Sold by International Assets Investment Management LLC - MarketBeat
Kuehn Law Encourages Investors of Progyny, Inc. to Contact Law Firm - PR Newswire
Progyny Stock Saw Big Buys From the CEO and a Former CEO - MSN
Brokerages Set Progyny, Inc. (NASDAQ:PGNY) Price Target at $25.00 - MarketBeat
Is Now An Opportune Moment To Examine Progyny, Inc. (NASDAQ:PGNY)? - Simply Wall St
Progyny Stock Saw Big Buys From the CEO, and a Former CEO - Barron's
The Bottom Fishing Club: Progyny Reverses On Heavy Insider Buying (NASDAQ:PGNY) - Seeking Alpha
Progyny CEO & Director Acquires 136% More Stock - Yahoo Finance
Principal Financial Group Inc. Lowers Stake in Progyny, Inc. (NASDAQ:PGNY) - MarketBeat
Progyny (NASDAQ:PGNY) Shares Gap Up on Insider Buying Activity - MarketBeat
Progyny Chief Executive Officer Trades $3.03M In Company Stock - Benzinga
Bullish Move: David Schlanger Shows Confidence, Acquires $2.20M In Progyny Stock - Benzinga
Progyny, Inc. (PGNY): A Bull Case Theory - Insider Monkey
PGNY INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Progyny, Inc. and Encourages Investors to Contact the Firm! - The Eastern Progress Online
Insider Buying: Progyny, Inc. (NASDAQ:PGNY) Chairman Buys 150,000 Shares of Stock - MarketBeat
Progyny, Inc. (NASDAQ:PGNY) CEO Peter Anevski Purchases 209,500 Shares - MarketBeat
Insider Buying: David Schlanger Acquires 150,000 Shares of Progy - GuruFocus.com
Progyny CEO Peter Anevski buys $3 million in shares By Investing.com - Investing.com Nigeria
Finanzdaten der Progyny Inc-Aktie (PGNY)
Umsatz
Nettogewinn
Free Cashflow
ENV
7.02%
1.52%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):